238 related articles for article (PubMed ID: 22685599)
1. Constitutively active canonical NF-κB pathway induces severe bone loss in mice.
Otero JE; Chen T; Zhang K; Abu-Amer Y
PLoS One; 2012; 7(6):e38694. PubMed ID: 22685599
[TBL] [Abstract][Full Text] [Related]
2. RelB-induced expression of Cot, an MAP3K family member, rescues RANKL-induced osteoclastogenesis in alymphoplasia mice by promoting NF-κB2 processing by IKKα.
Taniguchi R; Fukushima H; Osawa K; Maruyama T; Yasuda H; Weih F; Doi T; Maki K; Jimi E
J Biol Chem; 2014 Mar; 289(11):7349-61. PubMed ID: 24488495
[TBL] [Abstract][Full Text] [Related]
3. The pivotal role of the alternative NF-kappaB pathway in maintenance of basal bone homeostasis and osteoclastogenesis.
Soysa NS; Alles N; Weih D; Lovas A; Mian AH; Shimokawa H; Yasuda H; Weih F; Jimi E; Ohya K; Aoki K
J Bone Miner Res; 2010 Apr; 25(4):809-18. PubMed ID: 19839765
[TBL] [Abstract][Full Text] [Related]
4. NF-kappaB p100 limits TNF-induced bone resorption in mice by a TRAF3-dependent mechanism.
Yao Z; Xing L; Boyce BF
J Clin Invest; 2009 Oct; 119(10):3024-34. PubMed ID: 19770515
[TBL] [Abstract][Full Text] [Related]
5. TNF Induction of NF-κB RelB Enhances RANKL-Induced Osteoclastogenesis by Promoting Inflammatory Macrophage Differentiation but also Limits It through Suppression of NFATc1 Expression.
Zhao Z; Hou X; Yin X; Li Y; Duan R; Boyce BF; Yao Z
PLoS One; 2015; 10(8):e0135728. PubMed ID: 26287732
[TBL] [Abstract][Full Text] [Related]
6. Alternative NF-κB Regulates RANKL-Induced Osteoclast Differentiation and Mitochondrial Biogenesis via Independent Mechanisms.
Zeng R; Faccio R; Novack DV
J Bone Miner Res; 2015 Dec; 30(12):2287-99. PubMed ID: 26094846
[TBL] [Abstract][Full Text] [Related]
7. Processing of the NF-kappa B2 precursor p100 to p52 is critical for RANKL-induced osteoclast differentiation.
Maruyama T; Fukushima H; Nakao K; Shin M; Yasuda H; Weih F; Doi T; Aoki K; Alles N; Ohya K; Hosokawa R; Jimi E
J Bone Miner Res; 2010 May; 25(5):1058-67. PubMed ID: 19874202
[TBL] [Abstract][Full Text] [Related]
8. LRP1 Suppresses Bone Resorption in Mice by Inhibiting the RANKL-Stimulated NF-κB and p38 Pathways During Osteoclastogenesis.
Lu D; Li J; Liu H; Foxa GE; Weaver K; Li J; Williams BO; Yang T
J Bone Miner Res; 2018 Oct; 33(10):1773-1784. PubMed ID: 29750835
[TBL] [Abstract][Full Text] [Related]
9. NF-κB pathway inhibition by anthrocyclic glycoside aloin is key event in preventing osteoclastogenesis in RAW264.7 cells.
Pengjam Y; Madhyastha H; Madhyastha R; Yamaguchi Y; Nakajima Y; Maruyama M
Phytomedicine; 2016 Apr; 23(4):417-28. PubMed ID: 27002412
[TBL] [Abstract][Full Text] [Related]
10. Immune Differentiation Regulator p100 Tunes NF-κB Responses to TNF.
Chatterjee B; Roy P; Sarkar UA; Zhao M; Ratra Y; Singh A; Chawla M; De S; Gomes J; Sen R; Basak S
Front Immunol; 2019; 10():997. PubMed ID: 31134075
[TBL] [Abstract][Full Text] [Related]
11. NF-kappaB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis.
Xing L; Bushnell TP; Carlson L; Tai Z; Tondravi M; Siebenlist U; Young F; Boyce BF
J Bone Miner Res; 2002 Jul; 17(7):1200-10. PubMed ID: 12096833
[TBL] [Abstract][Full Text] [Related]
12. RelB is the NF-kappaB subunit downstream of NIK responsible for osteoclast differentiation.
Vaira S; Johnson T; Hirbe AC; Alhawagri M; Anwisye I; Sammut B; O'Neal J; Zou W; Weilbaecher KN; Faccio R; Novack DV
Proc Natl Acad Sci U S A; 2008 Mar; 105(10):3897-902. PubMed ID: 18322009
[TBL] [Abstract][Full Text] [Related]
13. Conjugated linoleic acid inhibits osteoclast differentiation of RAW264.7 cells by modulating RANKL signaling.
Rahman MM; Bhattacharya A; Fernandes G
J Lipid Res; 2006 Aug; 47(8):1739-48. PubMed ID: 16702601
[TBL] [Abstract][Full Text] [Related]
14. Methylsulfonylmethane Inhibits RANKL-Induced Osteoclastogenesis in BMMs by Suppressing NF-κB and STAT3 Activities.
Joung YH; Darvin P; Kang DY; Sp N; Byun HJ; Lee CH; Lee HK; Yang YM
PLoS One; 2016; 11(7):e0159891. PubMed ID: 27447722
[TBL] [Abstract][Full Text] [Related]
15. The natural flavonoid galangin inhibits osteoclastic bone destruction and osteoclastogenesis by suppressing NF-κB in collagen-induced arthritis and bone marrow-derived macrophages.
Huh JE; Jung IT; Choi J; Baek YH; Lee JD; Park DS; Choi DY
Eur J Pharmacol; 2013 Jan; 698(1-3):57-66. PubMed ID: 22985747
[TBL] [Abstract][Full Text] [Related]
16. I{kappa}B kinase (IKK){beta}, but not IKK{alpha}, is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss.
Ruocco MG; Maeda S; Park JM; Lawrence T; Hsu LC; Cao Y; Schett G; Wagner EF; Karin M
J Exp Med; 2005 May; 201(10):1677-87. PubMed ID: 15897281
[TBL] [Abstract][Full Text] [Related]
17. Zoledronic acid inhibits RANK expression and migration of osteoclast precursors during osteoclastogenesis.
Kimachi K; Kajiya H; Nakayama S; Ikebe T; Okabe K
Naunyn Schmiedebergs Arch Pharmacol; 2011 Mar; 383(3):297-308. PubMed ID: 21225243
[TBL] [Abstract][Full Text] [Related]
18. Neogambogic Acid Suppresses Receptor Activator of Nuclear Factor κB Ligand (RANKL)-Induced Osteoclastogenesis by Inhibiting the JNK and NF-κB Pathways in Mouse Bone Marrow-Derived Monocyte/Macrophages.
Jin G; Wang FF; Li T; Jia DD; Shen Y; Xu HC
Med Sci Monit; 2018 Apr; 24():2569-2577. PubMed ID: 29698379
[TBL] [Abstract][Full Text] [Related]
19. Deletion of CD74, a putative MIF receptor, in mice enhances osteoclastogenesis and decreases bone mass.
Mun SH; Won HY; Hernandez P; Aguila HL; Lee SK
J Bone Miner Res; 2013 Apr; 28(4):948-59. PubMed ID: 23044992
[TBL] [Abstract][Full Text] [Related]
20. Selective inhibition of NF-kappa B blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo.
Jimi E; Aoki K; Saito H; D'Acquisto F; May MJ; Nakamura I; Sudo T; Kojima T; Okamoto F; Fukushima H; Okabe K; Ohya K; Ghosh S
Nat Med; 2004 Jun; 10(6):617-24. PubMed ID: 15156202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]